CSBR Key Statistics, Chart & Performance
The current stock price of CSBR is 7.21 USD. In the past month the price increased by 14.08%. In the past year, price decreased by -26.28%.
CSBR Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to CSBR. When comparing the yearly performance of all stocks, CSBR is a bad performer in the overall market: 77.52% of all stocks are doing better.
CSBR Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to CSBR. There are concerns on the financial health of CSBR while its profitability can be described as average.
CSBR Financial Highlights
Over the last trailing twelve months CSBR reported a non-GAAP Earnings per Share(EPS) of 0.33. The EPS increased by 3200% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.27% | ||
| ROA | 8.26% | ||
| ROE | 59.76% | ||
| Debt/Equity | 0.01 |
CSBR Forecast & Estimates
7 analysts have analysed CSBR and the average price target is 12.24 USD. This implies a price increase of 69.76% is expected in the next year compared to the current price of 7.21.
For the next year, analysts expect an EPS growth of -50.13% and a revenue growth 3.41% for CSBR
CSBR Ownership
CSBR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 27.62 | 232.46B | ||
| DHR | DANAHER CORP | 30.61 | 166.69B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 188.8 | 57.37B | ||
| IQV | IQVIA HOLDINGS INC | 20.44 | 40.48B | ||
| A | AGILENT TECHNOLOGIES INC | 25.03 | 39.59B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 34.91 | 29.84B | ||
| WAT | WATERS CORP | 30.5 | 23.06B | ||
| ILMN | ILLUMINA INC | 32.49 | 21.64B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 36.75 | 18.69B | ||
| MEDP | MEDPACE HOLDINGS INC | 42.72 | 17.21B | ||
| RVTY | REVVITY INC | 23.49 | 12.76B | ||
| TEM | TEMPUS AI INC | N/A | 12.51B |
Related stock screener links
About CSBR
Company Profile
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Hackensack, New Jersey and currently employs 213 full-time employees. The firm is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. The company also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
Company Info
CHAMPIONS ONCOLOGY INC
One University Plaza,, Suite 307
Hackensack NEW JERSEY 07601 US
CEO: Ronnie Morris
Employees: 210
Phone: 12018088400
CHAMPIONS ONCOLOGY INC / CSBR FAQ
What does CSBR do?
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Hackensack, New Jersey and currently employs 213 full-time employees. The firm is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. The company also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
Can you provide the latest stock price for CHAMPIONS ONCOLOGY INC?
The current stock price of CSBR is 7.21 USD. The price increased by 0.52% in the last trading session.
What is the dividend status of CHAMPIONS ONCOLOGY INC?
CSBR does not pay a dividend.
What is the ChartMill rating of CHAMPIONS ONCOLOGY INC stock?
CSBR has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the analyst forecast for CSBR stock?
7 analysts have analysed CSBR and the average price target is 12.24 USD. This implies a price increase of 69.76% is expected in the next year compared to the current price of 7.21.
Would investing in CHAMPIONS ONCOLOGY INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CSBR.
Can you provide the number of employees for CHAMPIONS ONCOLOGY INC?
CHAMPIONS ONCOLOGY INC (CSBR) currently has 210 employees.